Cas Medical Sys Inc (CASM) 1.84 $CASM
CASMED to Report Second Quarter 2016 Financial Results and Hold Conference Call on August 4
GlobeNewswire - Thu Jul 28, 7:00AM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the second quarter of 2016 on Thursday, August 4, 2016, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.
CASM: 1.84 (+0.04)
CASMED to Present at Upcoming Investment Conferences
GlobeNewswire - Wed May 25, 7:00AM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring of cerebral oxygenation, announces that management will present at two upcoming investment conferences:
CASM: 1.84 (+0.04)
CASMED Reports First-Quarter 2016 Financial Results
GlobeNewswire - Thu May 05, 7:00AM CDT
Net sales increase 21%, FORE-SIGHT sales up 31%
CASM: 1.84 (+0.04)
CASMED to Report First Quarter 2016 Financial Results and Hold Conference Call on May 5
GlobeNewswire - Thu Apr 28, 11:47AM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in non-invasive monitoring of cerebral oxygenation, announces that it will report financial results for the first quarter of 2016 on Thursday, May 5, 2016, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.
CASM: 1.84 (+0.04)
Trinity Medical Devices Acquires Neonatal Product Line From CASMED
PR Newswire - Tue Mar 29, 9:30PM CDT
Trinity Medical Devices Inc., a company intensely focused on delivering high-quality single use medical products at lower costs to the global health care market; today announced the purchase of assets related to CAS Medical Systems, Inc. neonatal intensive care disposables product line. The purchase is in the amount of $3.35 million, with up to $400,000 of additional proceeds if certain sales targets are reached within the next 12 months. The neonatal product line includes the Klear-Trace® electrodes and NEOGUARD® disposable temperature probes, reflectors, and arm boards.
CASM: 1.84 (+0.04)
CASMED Sells Neonatal Intensive Care Disposables Product Line
GlobeNewswire - Tue Mar 29, 3:20PM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the sale of assets related to its neonatal intensive care disposables product line to Trinity Medical Devices Inc. The sale is in the amount of $3.35 million, subject to certain inventory adjustments, with up to $400,000 of additional proceeds if certain sales targets are reached within the next 12 months. The product-line sale provides additional working capital for the Company's investments in its core business, the FORE-SIGHT(R) cerebral oximetry products.
CASM: 1.84 (+0.04)
CASMED Reports 2015 Fourth Quarter and Full Year Financial Results
GlobeNewswire - Wed Mar 09, 7:22AM CST
Fourth Quarter U.S. FORE-SIGHT Sales Increase 38% and Include 24% Growth in U.S. Disposable Sensor Sales
CASM: 1.84 (+0.04)
CASMED to Present at the ROTH Conference
GlobeNewswire - Mon Mar 07, 7:00AM CST
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will present at the 28 Annual ROTH Conference on Monday, March 14, 2016, at 7:00 a.m. Pacific time (10:00 a.m. Eastern time). The conference is being held at The Ritz Carlton Laguna Niguel hotel in Dana Point, California.
CASM: 1.84 (+0.04)
CASMED Reports Preliminary Net Sales for the 2015 Fourth Quarter and Full Year
GlobeNewswire - Thu Jan 07, 7:00AM CST
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, reports preliminary unaudited top-line results for the three and 12 months ended December 31, 2015.
CASM: 1.84 (+0.04)
Global Hemodynamic Monitoring System Market - Analysis, Trends, Technologies & Forecast 2015-2020
M2 - Mon Dec 07, 5:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/gt2jcj/hemodynamic) has announced the addition of the "Hemodynamic Monitoring System Market: By Product, By End Users (Hospitals,Cath Labs,Clinics) - Forecast (2015-2020)" report to their offering. The Hemodynamic Monitoring System market is segregated on the basis of type; Minimally Invasive Hemodynamic Monitoring System, Invasive Hemodynamic Monitoring System and Noninvasive Hemodynamic Monitoring System. With the minimally invasive and noninvasive techniques at the fore, an increasing number of clinicians can conduct cardiac monitoring. The Hemodynamic Monitoring System market is also differentiated on the basis of products. There are two types of products, namely; Pulmonary Artery Catheters and Cardiac Output Monitoring System. In terms of the end user, Hemodynamic Monitoring System finds its application in Hospitals, Cath labs and Clinics. The adoption rate among Hospitals in the U.S. is high. The clinicians are slowly embracing the technology and the adoption trend is estimated to be positive in the future. The report also contains detailed and in-depth analysis of the segmentation of the Hemodynamic Monitoring System market with respect to geographic regions The regions contained in the report have been segmented into North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). These regions are further categorized into eminent countries from the perspective of Hemodynamic Monitoring System market. Companies Mentioned: - Cardio-Dynamics International - CAS Medical Systems - Cheetah Medical - Deltex Medical Sciences, Inc - Draeger Medical, Inc - Edwards Lifesciences - GE Healthcare - Hemo Sapiens, Inc - LiDCO Group plc - Noninvasive Medical Technologies, Inc - Philips Medical Systems - Pulsion Medical Systems - Schwarzer Cardiotek GmbH - Tensys Medical, Inc - Vasamed Report Structure: 1. Hemodynamic Monitoring Systems Market - Market Overview 2. Executive Summary 3. Hemodynamic Monitoring Systems Market - Market Landscape 4. Hemodynamic Monitoring Systems Market - Market Forces 5. Hemodynamic Monitoring Systems Market - Strategic Analysis 6. Hemodynamic Monitoring Systems Market - By Product 7. Hemodynamic Monitoring Systems Market - By Type 8. Hemodynamic Monitoring Systems Market - By End User 9. Hemodynamic Monitoring Systems Market - Geographic Analysis 10. Market Entropy 11. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio) 12. Appendix For more information visit http://www.researchandmarkets.com/research/gt...emodynamic
CASM: 1.84 (+0.04), EW: 114.23 (-0.29)
CASMED to Present at LD Micro Main Event
GlobeNewswire - Thu Nov 19, 7:00AM CST
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will present at the LD Micro Main Event on Wednesday, December 2, 2015, at 9:30 a.m. Pacific time. The conference will be held at the Luxe Sunset Boulevard Hotel in Los Angeles.
CASM: 1.84 (+0.04)
CASMED Reports Third Quarter 2015 Financial Results
GlobeNewswire - Thu Nov 05, 7:00AM CST
FORE-SIGHT Disposable Sensor Sales Increase 30%, Represent 62% of Net Sales
CASM: 1.84 (+0.04)
CASMED to Report Third Quarter 2015 Financial Results and Hold Conference Call on November 5
GlobeNewswire - Thu Oct 29, 3:05PM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the third quarter of 2015 on Thursday, November 5, 2015, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.
CASM: 1.84 (+0.04)
CASMED Sells Vital Signs Monitoring Line, Tightens Focus on FORE-SIGHT Cerebral Oximetry Business
GlobeNewswire - Thu Oct 29, 7:00AM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the sale of assets related to its 740 SELECT(R) vital signs monitoring product line to Zoe Medical, Inc. The sale of the 740 SELECT product line coupled with the phase-out of earlier generation monitors completes the Company's exit from the vital signs monitoring market.
CASM: 1.84 (+0.04)
Brain Monitoring Devices Market 2014-2020 - Global Strategic Business Report 2015
M2 - Wed Oct 21, 3:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fksxww/brain_monitoring) has announced the addition of the "Brain Monitoring Devices - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Brain Monitoring Devices in US$. The Global market is further analyzed by the following Product Segments: IntraCranial Pressure (ICP) Monitors, Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 38 companies including many key and niche players such as - Advanced Brain Monitoring, Inc. (US) - Cadwell Laboratories, Inc. (US) - CAS Medical Systems (US) - Compumedics, Ltd. (Australia) - Compumedics Germany GmbH (Germany) - DePuy Synthes Companies (US) - Elekta AB (Sweden) - Electrical Geodesics, Inc. (US) - HeadSense Medical, Inc. (US) - Integra Life Sciences Corporation (US) - Masimo Corporation (US) - Medtronic, Plc. (Ireland) - MEG International Services Ltd. (Canada) - Natus Medical Incorporated (US) - NeuroWave Systems, Inc. (US) - Nihon Kohden Corporation (Japan) - Nonin Medical, Inc. (US) - Ornim Medical (Israel) - Rimed, Inc. (US) - Spiegelberg GmbH (Germany) - Third Eye Diagnostics, Inc. (US) - Vittamed Corporation (US) - Yokogawa Electric Corporation (Japan) Key Topics Covered: 1. Industry Overview 2. EEG - The Largest Brain Monitoring Devices Segment 3. A Focus On Other Brain Monitoring Devices 4. Competitive Landscape 5. Market Trends, Issues & Drivers 6. Product Overview 7. Product Introductions/Innovations 8. Recent Industry Activity 9. Focus On Select Major Players 10. Global Market Perspective Total Companies Profiled: 38 (including Divisions/Subsidiaries - 41) - The United States (20) - Canada (1) - Japan (2) - Europe (12) - - France (2) - - Germany (3) - - The United Kingdom (1) - - Italy (1) - - Spain (1) - - Rest of Europe (4) - Asia-Pacific (Excluding Japan) (4) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/fk...monitoring
BABY: 39.18 (-0.15), MASI: 52.93 (-0.04), MDT: 88.06 (+0.43), CASM: 1.84 (+0.04)
CASMED Names Kimberly Strusky Executive Vice President of U.S. Sales
GlobeNewswire - Mon Oct 05, 7:30AM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces it has named Kimberly K. Strusky as Executive Vice President of U.S. Sales. Ms. Strusky brings to CASMED more than 25 years of sales experience in the medical device industry.
CASM: 1.84 (+0.04)
Misonix Appoints Thomas M. Patton to Board of Directors
PR Newswire - Tue Sep 22, 7:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, announced the addition of Mr. Thomas M. Patton to the Company's Board of Directors. Mr. Patton will replace the vacancy left by the resignation of Thomas O'Neill on May 13, 2015.
MSON: 6.22 (+0.12), CASM: 1.84 (+0.04), WMGIZ: 1.27 (-0.12)
CASMED to Present at Craig-Hallum Alpha Select Conference
GlobeNewswire - Thu Sep 10, 7:00AM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will present at the 6 Annual Craig-Hallum Alpha Select Conference on Thursday, September 17, 2015, at 2:50 p.m. Eastern time. The conference will be held at the Convene Conference Center in New York City.
CASM: 1.84 (+0.04)
Global EEG/EMG Equipment Market 2015 Report With Forecasts to 2019
M2 - Wed Aug 12, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9lcwpq/global_eegemg) has announced the addition of the "Global EEG/EMG Equipment Market 2015-2019" report to their offering. According to the report, the global EEG/EMG equipment market to grow at a CAGR of 7.57% over the period 2014-2019. EEG/EMG equipment is used to diagnose neurological disorders such as epilepsy, dementia, multiple sclerosis, and amyotrophic lateral sclerosis. The primary clinical use of EEG is to diagnose epilepsy. According to WHO, epilepsy will affect 50 million people worldwide by 2015, with 80% of patients living in low and middle-income countries. Further, approximately 2.4 million people are diagnosed with epilepsy every year worldwide. EMG is used as a diagnostic procedure for neuromuscular disorders. Duchenne-Becker muscular dystrophy affects one out of every 5,600-7,700 males between five and 24 years old in the US. The need for early diagnosis and for brain activity monitoring during the treatment of neurological disorders could drive market growth in the future. Further, the report states that the availability of other neuroimaging techniques hinders market growth. Key Topics Covered - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product Type - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and Their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and Their Impact - Vendor Landscape - Key Vendor Analysis Companies Mentioned - Advanced Brain Monitoring - CAS Medical Systems - Cadwell Laboratories - Compumedics - Delsys - EBNeuro - ELEKTA - EMS Biomedical - Electrical Geodesics - Integra Life Sciences - Masimo - Medtronic - Motion Lab Systems - Natus Medical - NeuroWave Systems - Neurosoft Company - Nihon Kohden - Noraxon USA For more information visit http://www.researchandmarkets.com/research/9l...bal_eegemg
BABY: 39.18 (-0.15), MDT: 88.06 (+0.43), CASM: 1.84 (+0.04)
CASMED Reports Second Quarter 2015 Financial Results
GlobeNewswire - Wed Aug 05, 7:00AM CDT
FORE-SIGHT(R)Disposable Sensor Revenues Increase 22%, Represent 55% of Total Sales
CASM: 1.84 (+0.04)
CASMED to Report Second Quarter 2016 Financial Results and Hold Conference Call on August 4
GlobeNewswire - Thu Jul 28, 7:00AM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the second quarter of 2016 on Thursday, August 4, 2016, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.
CASM: 1.84 (+0.04)
CASMED to Present at Upcoming Investment Conferences
GlobeNewswire - Wed May 25, 7:00AM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring of cerebral oxygenation, announces that management will present at two upcoming investment conferences:
CASM: 1.84 (+0.04)
CASMED Reports First-Quarter 2016 Financial Results
GlobeNewswire - Thu May 05, 7:00AM CDT
Net sales increase 21%, FORE-SIGHT sales up 31%
CASM: 1.84 (+0.04)
CASMED to Report First Quarter 2016 Financial Results and Hold Conference Call on May 5
GlobeNewswire - Thu Apr 28, 11:47AM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in non-invasive monitoring of cerebral oxygenation, announces that it will report financial results for the first quarter of 2016 on Thursday, May 5, 2016, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.
CASM: 1.84 (+0.04)
Trinity Medical Devices Acquires Neonatal Product Line From CASMED
PR Newswire - Tue Mar 29, 9:30PM CDT
Trinity Medical Devices Inc., a company intensely focused on delivering high-quality single use medical products at lower costs to the global health care market; today announced the purchase of assets related to CAS Medical Systems, Inc. neonatal intensive care disposables product line. The purchase is in the amount of $3.35 million, with up to $400,000 of additional proceeds if certain sales targets are reached within the next 12 months. The neonatal product line includes the Klear-Trace® electrodes and NEOGUARD® disposable temperature probes, reflectors, and arm boards.
CASM: 1.84 (+0.04)
CASMED Sells Neonatal Intensive Care Disposables Product Line
GlobeNewswire - Tue Mar 29, 3:20PM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the sale of assets related to its neonatal intensive care disposables product line to Trinity Medical Devices Inc. The sale is in the amount of $3.35 million, subject to certain inventory adjustments, with up to $400,000 of additional proceeds if certain sales targets are reached within the next 12 months. The product-line sale provides additional working capital for the Company's investments in its core business, the FORE-SIGHT(R) cerebral oximetry products.
CASM: 1.84 (+0.04)
CASMED Reports 2015 Fourth Quarter and Full Year Financial Results
GlobeNewswire - Wed Mar 09, 7:22AM CST
Fourth Quarter U.S. FORE-SIGHT Sales Increase 38% and Include 24% Growth in U.S. Disposable Sensor Sales
CASM: 1.84 (+0.04)
CASMED to Present at the ROTH Conference
GlobeNewswire - Mon Mar 07, 7:00AM CST
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will present at the 28 Annual ROTH Conference on Monday, March 14, 2016, at 7:00 a.m. Pacific time (10:00 a.m. Eastern time). The conference is being held at The Ritz Carlton Laguna Niguel hotel in Dana Point, California.
CASM: 1.84 (+0.04)
CASMED Reports Preliminary Net Sales for the 2015 Fourth Quarter and Full Year
GlobeNewswire - Thu Jan 07, 7:00AM CST
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, reports preliminary unaudited top-line results for the three and 12 months ended December 31, 2015.
CASM: 1.84 (+0.04)
Global Hemodynamic Monitoring System Market - Analysis, Trends, Technologies & Forecast 2015-2020
M2 - Mon Dec 07, 5:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/gt2jcj/hemodynamic) has announced the addition of the "Hemodynamic Monitoring System Market: By Product, By End Users (Hospitals,Cath Labs,Clinics) - Forecast (2015-2020)" report to their offering. The Hemodynamic Monitoring System market is segregated on the basis of type; Minimally Invasive Hemodynamic Monitoring System, Invasive Hemodynamic Monitoring System and Noninvasive Hemodynamic Monitoring System. With the minimally invasive and noninvasive techniques at the fore, an increasing number of clinicians can conduct cardiac monitoring. The Hemodynamic Monitoring System market is also differentiated on the basis of products. There are two types of products, namely; Pulmonary Artery Catheters and Cardiac Output Monitoring System. In terms of the end user, Hemodynamic Monitoring System finds its application in Hospitals, Cath labs and Clinics. The adoption rate among Hospitals in the U.S. is high. The clinicians are slowly embracing the technology and the adoption trend is estimated to be positive in the future. The report also contains detailed and in-depth analysis of the segmentation of the Hemodynamic Monitoring System market with respect to geographic regions The regions contained in the report have been segmented into North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). These regions are further categorized into eminent countries from the perspective of Hemodynamic Monitoring System market. Companies Mentioned: - Cardio-Dynamics International - CAS Medical Systems - Cheetah Medical - Deltex Medical Sciences, Inc - Draeger Medical, Inc - Edwards Lifesciences - GE Healthcare - Hemo Sapiens, Inc - LiDCO Group plc - Noninvasive Medical Technologies, Inc - Philips Medical Systems - Pulsion Medical Systems - Schwarzer Cardiotek GmbH - Tensys Medical, Inc - Vasamed Report Structure: 1. Hemodynamic Monitoring Systems Market - Market Overview 2. Executive Summary 3. Hemodynamic Monitoring Systems Market - Market Landscape 4. Hemodynamic Monitoring Systems Market - Market Forces 5. Hemodynamic Monitoring Systems Market - Strategic Analysis 6. Hemodynamic Monitoring Systems Market - By Product 7. Hemodynamic Monitoring Systems Market - By Type 8. Hemodynamic Monitoring Systems Market - By End User 9. Hemodynamic Monitoring Systems Market - Geographic Analysis 10. Market Entropy 11. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio) 12. Appendix For more information visit http://www.researchandmarkets.com/research/gt...emodynamic
CASM: 1.84 (+0.04), EW: 114.23 (-0.29)
CASMED to Present at LD Micro Main Event
GlobeNewswire - Thu Nov 19, 7:00AM CST
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will present at the LD Micro Main Event on Wednesday, December 2, 2015, at 9:30 a.m. Pacific time. The conference will be held at the Luxe Sunset Boulevard Hotel in Los Angeles.
CASM: 1.84 (+0.04)
CASMED Reports Third Quarter 2015 Financial Results
GlobeNewswire - Thu Nov 05, 7:00AM CST
FORE-SIGHT Disposable Sensor Sales Increase 30%, Represent 62% of Net Sales
CASM: 1.84 (+0.04)
CASMED to Report Third Quarter 2015 Financial Results and Hold Conference Call on November 5
GlobeNewswire - Thu Oct 29, 3:05PM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the third quarter of 2015 on Thursday, November 5, 2015, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.
CASM: 1.84 (+0.04)
CASMED Sells Vital Signs Monitoring Line, Tightens Focus on FORE-SIGHT Cerebral Oximetry Business
GlobeNewswire - Thu Oct 29, 7:00AM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the sale of assets related to its 740 SELECT(R) vital signs monitoring product line to Zoe Medical, Inc. The sale of the 740 SELECT product line coupled with the phase-out of earlier generation monitors completes the Company's exit from the vital signs monitoring market.
CASM: 1.84 (+0.04)
Brain Monitoring Devices Market 2014-2020 - Global Strategic Business Report 2015
M2 - Wed Oct 21, 3:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fksxww/brain_monitoring) has announced the addition of the "Brain Monitoring Devices - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Brain Monitoring Devices in US$. The Global market is further analyzed by the following Product Segments: IntraCranial Pressure (ICP) Monitors, Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 38 companies including many key and niche players such as - Advanced Brain Monitoring, Inc. (US) - Cadwell Laboratories, Inc. (US) - CAS Medical Systems (US) - Compumedics, Ltd. (Australia) - Compumedics Germany GmbH (Germany) - DePuy Synthes Companies (US) - Elekta AB (Sweden) - Electrical Geodesics, Inc. (US) - HeadSense Medical, Inc. (US) - Integra Life Sciences Corporation (US) - Masimo Corporation (US) - Medtronic, Plc. (Ireland) - MEG International Services Ltd. (Canada) - Natus Medical Incorporated (US) - NeuroWave Systems, Inc. (US) - Nihon Kohden Corporation (Japan) - Nonin Medical, Inc. (US) - Ornim Medical (Israel) - Rimed, Inc. (US) - Spiegelberg GmbH (Germany) - Third Eye Diagnostics, Inc. (US) - Vittamed Corporation (US) - Yokogawa Electric Corporation (Japan) Key Topics Covered: 1. Industry Overview 2. EEG - The Largest Brain Monitoring Devices Segment 3. A Focus On Other Brain Monitoring Devices 4. Competitive Landscape 5. Market Trends, Issues & Drivers 6. Product Overview 7. Product Introductions/Innovations 8. Recent Industry Activity 9. Focus On Select Major Players 10. Global Market Perspective Total Companies Profiled: 38 (including Divisions/Subsidiaries - 41) - The United States (20) - Canada (1) - Japan (2) - Europe (12) - - France (2) - - Germany (3) - - The United Kingdom (1) - - Italy (1) - - Spain (1) - - Rest of Europe (4) - Asia-Pacific (Excluding Japan) (4) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/fk...monitoring
BABY: 39.18 (-0.15), MASI: 52.93 (-0.04), MDT: 88.06 (+0.43), CASM: 1.84 (+0.04)
CASMED Names Kimberly Strusky Executive Vice President of U.S. Sales
GlobeNewswire - Mon Oct 05, 7:30AM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces it has named Kimberly K. Strusky as Executive Vice President of U.S. Sales. Ms. Strusky brings to CASMED more than 25 years of sales experience in the medical device industry.
CASM: 1.84 (+0.04)
Misonix Appoints Thomas M. Patton to Board of Directors
PR Newswire - Tue Sep 22, 7:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, announced the addition of Mr. Thomas M. Patton to the Company's Board of Directors. Mr. Patton will replace the vacancy left by the resignation of Thomas O'Neill on May 13, 2015.
MSON: 6.22 (+0.12), CASM: 1.84 (+0.04), WMGIZ: 1.27 (-0.12)
CASMED to Present at Craig-Hallum Alpha Select Conference
GlobeNewswire - Thu Sep 10, 7:00AM CDT
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will present at the 6 Annual Craig-Hallum Alpha Select Conference on Thursday, September 17, 2015, at 2:50 p.m. Eastern time. The conference will be held at the Convene Conference Center in New York City.
CASM: 1.84 (+0.04)
Global EEG/EMG Equipment Market 2015 Report With Forecasts to 2019
M2 - Wed Aug 12, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9lcwpq/global_eegemg) has announced the addition of the "Global EEG/EMG Equipment Market 2015-2019" report to their offering. According to the report, the global EEG/EMG equipment market to grow at a CAGR of 7.57% over the period 2014-2019. EEG/EMG equipment is used to diagnose neurological disorders such as epilepsy, dementia, multiple sclerosis, and amyotrophic lateral sclerosis. The primary clinical use of EEG is to diagnose epilepsy. According to WHO, epilepsy will affect 50 million people worldwide by 2015, with 80% of patients living in low and middle-income countries. Further, approximately 2.4 million people are diagnosed with epilepsy every year worldwide. EMG is used as a diagnostic procedure for neuromuscular disorders. Duchenne-Becker muscular dystrophy affects one out of every 5,600-7,700 males between five and 24 years old in the US. The need for early diagnosis and for brain activity monitoring during the treatment of neurological disorders could drive market growth in the future. Further, the report states that the availability of other neuroimaging techniques hinders market growth. Key Topics Covered - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product Type - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and Their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and Their Impact - Vendor Landscape - Key Vendor Analysis Companies Mentioned - Advanced Brain Monitoring - CAS Medical Systems - Cadwell Laboratories - Compumedics - Delsys - EBNeuro - ELEKTA - EMS Biomedical - Electrical Geodesics - Integra Life Sciences - Masimo - Medtronic - Motion Lab Systems - Natus Medical - NeuroWave Systems - Neurosoft Company - Nihon Kohden - Noraxon USA For more information visit http://www.researchandmarkets.com/research/9l...bal_eegemg
BABY: 39.18 (-0.15), MDT: 88.06 (+0.43), CASM: 1.84 (+0.04)
CASMED Reports Second Quarter 2015 Financial Results
GlobeNewswire - Wed Aug 05, 7:00AM CDT
FORE-SIGHT(R)Disposable Sensor Revenues Increase 22%, Represent 55% of Total Sales
CASM: 1.84 (+0.04)
